Ikesia Biologics Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 13-01-2025
- Paid Up Capital ₹ 0.50 M
as on 13-01-2025
- Company Age 2 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
as on 13-01-2025
About Ikesia Biologics
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹5.00 M.
Sawraj Singh and Rekha Nagpal serve as directors at the Company.
- CIN/LLPIN
U73100KA2022PTC162282
- Company No.
162282
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jun 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ikesia Biologics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sawraj Singh  | Director | 10-Jun-2022 | Current |
| Rekha Nagpal | Director | 19-Oct-2022 | Current |
Financial Performance of Ikesia Biologics.
Enhance accessibility to Ikesia Biologics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ikesia Biologics?
Unlock access to Ikesia Biologics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Dec 2023 | ₹4.40 M | Open |
Others Creation Date: 22 Dec 2023 | ₹0.60 M | Open |
How Many Employees Work at Ikesia Biologics?
Ikesia Biologics has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ikesia Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ikesia Biologics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
